XML 25 R15.htm IDEA: XBRL DOCUMENT

Inventory

9 Months Ended

Sep. 30, 2023

Inventory [Abstract]

Inventory

Inventory as of September 30, 2023 and December 31, 2022 consisted of the following:


(in KUSD)						As of September 30, 2023						As of December 31, 2022

Work in process						22,170						18,165
Finished goods						558						399
Total inventory						22,728						18,564

Impairment charges of KUSD nil and KUSD 872 were recognized and charged to cost of product sales in the unaudited condensed consolidated interim statement of operations during the three and nine months ended September 30, 2023, respectively.For the nine months ended September 30, 2022, the Company designated certain capitalized pre-approval ZYNLONTA inventory for R&D use and recorded a charge to R&D expenses, which was partially offset by a reversal of previously recorded impairment charges. The net impact of KUSD nil and KUSD 75 was recorded as an expense to R&D in the Company’s unaudited condensed consolidated interim statement of operation for the three and nine months ended September 30, 2022, respectively. The reversal of previously recorded impairment charges is based on the existence of inventory on hand and estimated demand, as well as expiration dating.